metformin has been researched along with 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde o-(3,4-dichlorobenzyl)oxime in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garzel, B; Heyward, S; Moeller, T; Shapiro, P; Wang, H; Yang, H | 1 |
1 other study(ies) available for metformin and 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde o-(3,4-dichlorobenzyl)oxime
Article | Year |
---|---|
Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling.
Topics: Active Transport, Cell Nucleus; AMP-Activated Protein Kinases; Aryl Hydrocarbon Hydroxylases; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B6; Dose-Response Relationship, Drug; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoglycemic Agents; Metformin; Oximes; p38 Mitogen-Activated Protein Kinases; Phenobarbital; Phosphorylation; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles | 2014 |